As this distinction does not change management or prognosis but causes significant confusion due to alternate definitions and misunderstandings, it is generally established that pathophysiological discussions of "dry" versus "wet" drowning are not relevant to drowning care. "Dry drowning" is frequently cited in the news with a wide variety of definitions. and is often confused with the equally inappropriate and discredited term "secondary drowning" or "delayed drowning". Various conditions including spontaneous pneumothorax, chemical pneumonitis, bacterial or viral pneumonia, head injury, asthma, heart attack, and chest trauma have been misattributed to the erroneous terms "delayed drowning," "secondary drowning," and "dry drowning." Currently, there has never been a case identified in the medical literature where a person was observed to be without symptoms and who died hours or days later as a direct result of drowning alone. Capital punishment
In Europe, drowning was used as capital punishment. During the Middle Ages, a sentence of death was read using the words cum fossa et furca, or "with pit and gallows".Drowning survived as a method of execution in Europe until the 17th and 18th centuries. England had abolished the practice by 1623, Scotland by 1685, Switzerland in 1652, Austria in 1776, Iceland in 1777, and Russia by the beginning of the 1800s. France revived the practice during the French Revolution (1789–1799) and it was carried out by Jean-Baptiste Carrier at Nantes. References
External links
Canadian Red Cross: Drowning Research: Drownings in Canada, 10 Years of Research Module 2 – Ice & Cold Water Immersion
The Enterobacteriaceae, Acinetobacter species, and Pseudomonas species are intrinsically resistant to rifampicin.It has been used with amphotericin B in largely unsuccessful attempts to treat primary amoebic meningoencephalitis caused by Naegleria fowleri.Rifampicin can be used as monotherapy for a few days as prophylaxis against meningitis, but resistance develops quickly during long-term treatment of active infections, so the drug is always used against active infections in combination with other antibiotics.Rifampicin is relatively ineffective against spirochetes, which has led to its use as a selective agent capable of isolating them in materials being cultured in laboratories. Viruses
Rifampicin has some effectiveness against vaccinia virus. Pathogen susceptibility
The minimum inhibitory concentrations of rifampicin for several medically significant pathogens are:

Mycobacterium tuberculosis — 0.002 – 64 µg/ml
Mycobacterium bovis — 0.125 µg/ml
Staphylococcus aureus (methicillin resistant) — ≤ 0.006–256 µg/ml
Chlamydia pneumoniae — 0.005 µg/ml

Primary biliary cholangitis
Rifampicin is used to treat itchiness caused by primary biliary cholangitis. The treatment-related adverse effects include hepatotoxicity, nephrotoxicity, hemolysis, and interactions with other drugs. For those reasons as well as some ethical concerns regarding off-label use of antibiotics, rifampin as a very effective preventive antibiotic for meningitis, is not considered appropriate for itchiness. Hidradenitis suppurativa
Rifampicin with clindamycin has been used to treat the skin disease hidradenitis suppurativa. Adverse effects
The most serious adverse effect is hepatotoxicity, and people receiving it often undergo baseline and frequent liver function tests to detect early liver damage.The more common side effects include fever, gastrointestinal disturbances, rashes, and immunological reactions.